I want to know where to start
Bring the line and the number. We map the wedge, the stack and the stakeholders.
Tell us the press, the coater or the granulator, the number that hurts and who owns it. The first call is a line review: your equipment, PAT and MES stack, the wedge workflow we would shadow first, and what QA will want to see.
Scenario: Run one immediate-release tablet batch through granulation, compression, coating and inspection inside the approved design space, with QA approval before release. A design walkthrough, not a customer record.
The more specific the line and the problem, the more useful the first call is. Every field is optional except the ones marked required.
Headquarters and a postal address will be published when the company is formed. Until then, email is the route.
Pick the closest.
Bring the line and the number. We map the wedge, the stack and the stakeholders.
We scope the baseline, the connectors and the QA involvement, and write the exchange down.
Architecture, data flows, audit-trail schema, validation approach and GAMP 5 package status.
OEMs, PAT and MES vendors, integrators and CSV consultancies.
Thesis, market, defensibility and the design-partner plan, with targets labelled.
Tell us which and what you have built that is closest to it.
This is the shape of the run your line would produce once the wedge workflow graduates from shadow mode.
Plant Orchestrator · Pulled the master batch record, the approved design-space limits for this formulation and tooling family, and the site autonomy policy from MES; locked the target envelope for the run.
Plant Orchestrator · Twindra simulated 36 candidate setpoint vectors on the as-made batch twin (granulation DEM, compression and ejection risk, coating CFD, dissolution surrogate) and ranked them on predicted content uniformity, capping risk and takt.
Blend-and-Dispense · Spectryn scored in-line NIR spectra against the formulation's chemometric model; the blend reached its uniformity end point with confidence bounds inside the site acceptance limit and blending stopped on evidence rather than on a fixed time.
Granulate-and-Dry · Inlet air temperature and drying airflow trimmed inside the approved window to bring loss-on-drying to the target moisture band for compression; the move was bounded, logged and inside the design space.
Compress-and-Fill · Main compression force and feed-frame speed adjusted inside the approved window to hold tablet weight and hardness on target while the twin's capping-risk estimate stayed under the site threshold.
Coat-and-Dry · Spray rate and inlet temperature re-phased against bed temperature and exhaust humidity to hold the film-coat window and avoid twinning and mottling; no excursion from the validated recipe envelope.
Defect-and-Inspect · Visqa classified chips, cracks, capping, spots, mottling and print defects on six synchronised cameras, within the sub-100 ms design budget, and linked a rising chip rate to coating spray rather than to tooling.
Quality-and-Potency · Spectryn assembled the method-linked evidence chain for content uniformity and moisture with confidence bounds and citations to the validated analytical method, ready for QA review.
Plant Orchestrator · Batch release is above every autonomy level Pildeon offers. The package was held for the named QA reviewer, who approved it in the review console; the decision, the reviewer identity and the timestamp are in the Part 11 audit trail.
Quality-and-Conformance · Conforma wrote the time-aligned batch genealogy (every sensor state, recommendation, approved action, equipment response and QC result) and the cited release package to the immutable audit trail.
Phases, not promises of dates; your validation calendar sets the pace.
One policy model, one audit spine, one benchmark across every line in every plant, with formulation and tooling models kept private to each site.
Land on one validated workflow with a measurable baseline. Expand by line, module, site and autonomy level. Outcome components are available on yield, rejects, deviations and energy.
Compression or coating control or inspection AI for one line. For OSD makers validating ROI on the wedge.
The whole loop: blend and dispense, granulate and dry, compress and fill, coat and dry, defect, quality and potency, yield and takt, robotic handling and the batch twin.
Pharma and CDMO groups standardising on Pildeon across sites, with custom formulation, tooling and tolerance models.
Annual prepay discounts run 15 to 20% depending on term; the toggle shows 15%. Usage metering applies above plan limits. Multi-year enterprise agreements carry usage ramps.
Pildeon writes to production equipment in a GMP plant. Every capability is scoped to the approved design space, every write is policy-checked, every action is written to an immutable Part 11 audit trail the site owns, and no agent can release a batch.
| Standard | Scope | Status |
|---|---|---|
| 21 CFR Part 11 | Audit trail, e-signatures, records | RUNNING Designed in from day one |
| GAMP 5 | Validation package for the platform | RUNNING In progress, planned for the first design partners |
| cGMP · ICH Q8 to Q13 | Design space, QbD, continuous manufacturing | RUNNING Design-aligned; site validation decides |
| SOC 2 Type I | Cloud control plane | QUEUED Planned, first six months |
| SOC 2 Type II | Cloud control plane | QUEUED Planned, months six to twelve |
| Data residency | Validated on-prem, air-gapped option | SUCCEEDED Available by design |
Pildeon has no customer quotes to show yet, and will not invent any. These are the questions the three buyers in an OSD plant ask in the first meeting, and the answer each gets.
"What does this do to my reject rate, my deviation count and my release time, and how will you prove it on my line rather than on a slide?"
Site or manufacturing director · economic buyerAnswer: shadow mode first, baseline captured before any autonomous action, a written ROI target before a paid pilot.
"Will it ever move a setpoint outside the design space we validated, and can I see why it recommended every move it made?"
Formulation or process engineer (MSAT) · championAnswer: no, by construction. Every recommendation carries its reasoning trace and its citation.
"Where is the Part 11 audit trail, who signs the release, and what happens to my validated state when the model changes?"
QA, quality and compliance lead · approverAnswer: an immutable audit spine, a named QA reviewer on every release, and every model change under GxP change control.
Pildeon reads and writes through the systems already on the floor: presses, coaters, granulators, PAT probes, MES, LIMS and historians. No rip-and-replace, no parallel historian. Connectors are built with design partners against their stacks; the vendors listed are the ones common in OSD plants.
GEA, Glatt, Syntegon, Freund-Vector, L.B. Bohle
Blender, granulator and fluid-bed telemetry; bounded setpoint writes
Fette Compacting, Korsch, IMA, Syntegon, MG2
Force curves, fill depth, ejection force; bounded setpoint writes
GEA, Glatt, O'Hara, Thomas, Freund
Spray, inlet, bed temperature, exhaust humidity; bounded writes
Bruker, Sartorius, Viavi probes and analysers
Spectra across blend, granulation, drying and compression
Line cameras and existing inspection systems
Frames, defect maps, reviewed images
Körber Werum PAS-X, Rockwell, Siemens Opcenter
Master batch records, campaigns, batch genealogy
Site LIMS, OSIsoft PI and equivalent historians
QC results, time-series backfill and replay
Azure AD, Okta, LDAP · NVIDIA Jetson and on-prem GPU
SSO, RBAC, named approvers · inference at the line
The questions site directors, MSAT engineers and QA leads actually ask in the first meeting.
Yes, but only inside an explicit setpoint allow-list bounded by the design space your validation approved, and only at the autonomy level your site has set. Level 0 is shadow mode: Pildeon observes and predicts and writes nothing. Most sites spend their first weeks there.
No. The approved design space is a wall the policy engine enforces at call time. A move outside it, or a change to a validated parameter, is a change-control event that waits for QA sign-off. No autonomy level removes that gate.
A named QA reviewer, every time. Pildeon assembles the evidence chain and the cited release package; the reviewer approves or rejects it in the review console, and the decision, identity and timestamp land in the Part 11 audit trail.
The line returns to the equipment's own last known-good recipe. Pildeon is a supervisory layer on top of your existing control systems, never a replacement, so an outage degrades the line to the way it runs today, not to a stop.
Only if you choose cloud training. Formulations, recipes, spectra and defect libraries are tenant-isolated and never used to train another customer's models. Validated on-prem deployment with an air-gapped plant edge is available.
Shadow mode on one wedge workflow first, with baseline rejects, deviations, yield, energy and release time captured before any autonomous action. Assist mode once prediction accuracy is shown against QC results. A paid validated pilot only when there is a written ROI target. Timelines depend on the site's validation and change-control calendar.
One email to hello@pildeon.com with the press, the number and the names. We take it from there.
↑↓ navigate↵ openesc close